Brii Biosciences Limited (HK:2137) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Brii Biosciences Limited has announced a share buy-back program, aiming to repurchase up to 10% of its issued shares, valued at no more than HK$60 million, reflecting confidence in its business prospects. This move comes as the company’s shares trade at a level deemed undervalued by the board, and the program will be funded by existing cash resources. Chairman Dr. Zhi Hong has also acquired additional shares, underscoring high confidence in the company’s future potential.
For further insights into HK:2137 stock, check out TipRanks’ Stock Analysis page.